Table 2. Demographic data for HSCT recipients without DE (non-DE/non-cGVHD group).
| Case | Age | Gender | HSCT source | Underlying disease | Interval between HSCT and CM analysis (mo) |
|---|---|---|---|---|---|
| 1 |
55 |
Male |
BM |
MM |
20 |
| 2 |
28 |
Male |
BM |
ALL |
168 |
| 3 |
52 |
Male |
PBSC |
CML |
24 |
| 4 |
62 |
Male |
BM |
AML |
72 |
| 5 |
26 |
Male |
BM |
MDS |
26 |
| 6 |
61 |
Female |
BM |
AML |
39 |
| 7 |
44 |
Female |
BM |
CML |
199 |
| 8 | 48 | Female | BM | AML | 177 |
HSCT=hematopoietic stem cell transplantation; CM=confocal microscopy; DE=dry eye; PBSC=peripheral blood stem cell; BM=bone marrow; MM=multiple myeloma; ALL=acute lymphocytic leukemia; CML=chronic myeloid leukemia; AML=acute myeloid leukemia; MDS=myelodysplastic syndrome.